Danielle Amani Naugle

Danielle Amani Naugle

Auto-generated profile, based on publicly available information

Danielle Amani Naugle

Johns Hopkins Center for Communication Programs

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DNDanielle Amani Naugle
Danielle Amani Naugle
NTNatalie Jean Tibbels
Natalie Jean Tibbels
ZHZoé Mistrale Hendrickson
Zoé Mistrale Hendrickson
ADAbdul Dosso
Abdul Dosso
LLLynn Van Lith
Lynn Van Lith
CHChristopher J Hoffmann
Christopher J Hoffmann
This qualitative research study explored the role of masculinity in men’s engagement in the HIV care continuum in Côte d’Ivoire. The researchers conducted 73 in-depth interviews and 28 focus group discussions with 227 Ivoirian men between November and December 2016 across three urban sites. Participants in the study expressed that fear was the primary barrier to HIV testing and treatment. These men described five value domains–health, sexuality, work and financial success, family, and social status. Men saw HIV as a direct threat to their agency and strength with respect to each of these value domains, thus shedding light on their reluctance to discover their HIV status through HIV testing. With this data, the researchers created the Masculine Values Framework, a descriptive framework of masculine values that can be applied to better understand the behavior men exhibit in Côte d’Ivoire in the face of HIV. The Masculine Values Framework offers practical guidance for developing gender-sensitive HIV-focused social and behavior change programming in Côte d’Ivoire and similar contexts to reach the UNAIDS 90-90-90 targets.

21 March 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NTNatalie Jean Tibbels
Natalie Jean Tibbels
ZHZoé Mistrale Hendrickson
Zoé Mistrale Hendrickson
DNDanielle Amani Naugle
Danielle Amani Naugle
ADAbdul Dosso
Abdul Dosso
LLLynn Van Lith
Lynn Van Lith
CHChristopher J. Hoffmann
Christopher J. Hoffmann
Men in sub-Saharan Africa have lower rates of HIV testing and are less likely to initiate treatment compared to women. Service delivery dimensions are a key factor in facilitating engagement along the HIV treatment continuum for men and women, yet male specific overall perceptions of the service delivery environment have received little attention in West Africa. This study draws on qualitative data collected in Côte d’Ivoire to explore provider-level and structural factors affecting men’s engagement in HIV testing and treatment through interviews and focus group discussions conducted with health workers and men living with HIV (some on ART) or whose HIV status was unknown. Factors influencing decisions to test or initiate treatment were considered in terms of perceived benefits and costs. Men described costs at the interpersonal (client-provider) level, such as unwanted disclosure or stigma, which were weighed against the potential for social support and clinical guidance. Likewise, fear of unwanted disclosure operated at the facility level, as the layout of facilities sometimes grouped clients living with HIV together. Notably, the benefits men described from engaging in HIV testing and care all operated at the interpersonal level and none at the facility level. In light of the fact that provider- and facility-level factors influenced the perceptions and experiences of men along the treatment continuum, we offer recommendations to reduce barriers to testing and engagement in care related to service delivery.

15 August 2020 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
DNDanielle A. Naugle
Danielle A. Naugle
ADAbdul Dosso
Abdul Dosso
NTNatalie J. Msph Tibbels
Natalie J. Msph Tibbels
LLLynn M. Mpa Van Lith
Lynn M. Mpa Van Lith
ZHZoé M. Hendrickson
Zoé M. Hendrickson
CHChristopher J. Hoffmann
Christopher J. Hoffmann
Background: Historically, men in sub-Saharan Africa have worse outcomes along the HIV care continuum than women. Brothers for Life (BFL) is a community-based behavior change intervention for men, adapted for Côte d'Ivoire, involving group discussions that address salient gender norms and promote HIV prevention, testing, and linkage to care with support from peer navigators. The goal of this study was to describe the BFL program as implemented in Côte d'Ivoire, evaluate program implementation, and report uptake of HIV testing and treatment among BFL participants. Setting: Three urban and periurban sites in Côte d'Ivoire. Methods: The implementation evaluation assessed the fidelity and acceptability of the BFL program and the reach of program completion, testing and peer navigation using qualitative and quantitative approaches. Results: BFL facilitation fidelity and content fidelity were high. Semistructured interviews with BFL participants indicated that men appreciated the format and content and that the BFL program helped some participants overcome their fears and adopt more positive attitudes and behaviors around testing and treatment. Assessments of reach showed that, of the 7187 BFL participants, 81% tested for HIV as part of BFL and 2.3% (135) tested HIV-positive. Of those, 76% (102) accepted peer navigator support, and 97% (131) initiated treatment. After 6 months, 100% of the 131 men who initiated treatment remained in care. Conclusion: The implementation of BFL in Côte d'Ivoire successfully achieved the goals of engaging participants in discussions around HIV prevention, encouraging HIV testing, and achieving linkage to care, treatment initiation, and retention.

24 August 2022 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
NTNatalie Jean Tibbels
Natalie Jean Tibbels
ADAbdul Dosso
Abdul Dosso
KKKouamé Walter Kra
Kouamé Walter Kra
KGKonan Dorgeles Gbeke
Konan Dorgeles Gbeke
GCGervais Coffi
Gervais Coffi
DNDanielle Amani Naugle
Danielle Amani Naugle
While vaccines are now authorized for use against the SARS-CoV2 virus, they remain inaccessible for much of the world and widespread hesitancy persists. Ending the COVID-19 pandemic depends on continued prevention behaviors such as mask wearing, distancing, hand hygiene, and limiting large gatherings. Research in low- and middle-income countries has focused on the prevalence of adherence and demographic determinants, but there is a need for a nuanced understanding of why people do or do not practice a given prevention behavior. The Breakthrough ACTION project led by Johns Hopkins Center for Communication Programs conducted a qualitative study in November 2020 in Côte d’Ivoire to explore people’s experience with and perceptions of the COVID-19 pandemic. We conducted 24 focus group discussions and 29 in-depth interviews with members of the general population and health providers. This analysis explores barriers and facilitators to seven recommended prevention behaviors with a particular focus on response efficacy, self-efficacy, and social norms. We found these constructs to be salient for participants who generally felt that the behaviors were useful for preventing COVID-19 but were difficult to practice for a variety of reasons. The perception that COVID-19 prevention behaviors were anti-social emerged as a key theme. Behavior change interventions must reframe the recommended behaviors as pro-social, while making them very easy to practice by removing social and structural barriers such as the expense or inaccessibility of masks and hand sanitizer.

4 January 2024
Verified
Book Chapter
Open access
PDF file
DNDanielle A. Naugle
Danielle A. Naugle
NTNatalie J. Tibbels
Natalie J. Tibbels
ADAbdul Dosso
Abdul Dosso
The Extended Parallel Process Model (EPPM) is a framework that describes how fear and perceived efficacy interact to shape behaviour. Fear is a natural response to a new and deadly pandemic like that caused by SARS-CoV-2 and fear often generates stigma. Qualitative research from Côte d’Ivoire suggests that risk communicators crafting fear appeals need to carefully consider how stigma is likely to interact with fear and perceived efficacy. Furthermore, responses to fear appeals change based on the phase of the pandemic; as the immediate threat wanes so does the ability to maintain protective behaviours in the longer term. Drawing on data from 24 focus groups and 27 in-depth interviews with members of the general population, health providers, survivors of COVID-19, and individuals who had lost a close family member to COVID-19 in Côte d’Ivoire, we integrate stigma and time into the EPPM to illustrate how fear, efficacy, and stigma shape behavior and evolve over time in response to the shifting landscape of the coronavirus pandemic in Côte d’Ivoire.

19 November 2023 in Vaccine
Verified
Journal Article
Open access
DNDanielle Naugle
Danielle Naugle
NTNatalie Tibbels
Natalie Tibbels
ADAbdul Dosso
Abdul Dosso
WBWilliam Benie
William Benie
MNMarjorie Nana
Marjorie Nana
In January 2023, almost two years after the COVID-19 vaccines were authorized for the general Ivorian population, the Government of Côte d'Ivoire authorized the Pfizer vaccine for pregnant women. Qualitative research with 214 adults (including pregnant women) in three Ivorian cities in November 2022 revealed that most participants knew that the COVID-19 vaccine had not been recommended for pregnant women. Some participants felt that the policy change alone would be enough to motivate pregnant women to get vaccinated, but others felt that it would be difficult to convince pregnant women that the vaccine is safe for them and their babies. Pregnant women who participated in the study expressed a preference for waiting until after giving birth to get vaccinated against COVID-19, to be safe. They viewed the COVID-19 vaccine as risky during pregnancy but seemed unaware of the heightened risks that COVID-19 illness poses to pregnant women and babies. Pregnant participants stated that if they believed that the COVID-19 vaccine was good for the baby they would put aside their fears and get vaccinated. Reframing the conversation around the dangers of COVID-19 for pregnant women and their babies and positioning the COVID-19 vaccine as safe during pregnancy and protective, both during pregnancy and afterwards, could encourage uptake among this important segment of the population. Potential strategies to reinforce perceptions of COVID-19 vaccine safety for pregnant women include frequent and consistent messaging through both interpersonal and mass media channels; leveraging prenatal consultations and the relationship between health workers and pregnant women for both counseling and vaccination; and engaging influential others to support pregnant women in the decision to accept vaccination against COVID-19. Positive testimonials may help combat rumors that the vaccine negatively affects fertility and reproductive health, which could help to foster positive attitudes towards the vaccine before a woman even becomes pregnant and encourage broad vaccination among women of reproductive age.